Buy Siemens Ltd For Target Rs.3,630 - ICICI Direct
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Decent performance…
About the stock: Siemens Ltd (Siemens) is a leader in technology solutions for smart, intelligent, building technologies, mobility, digital industries and power T&D.
* It operates mainly in five key segments including energy/gas & power (34%), smart infrastructure (33%), digital industries (22%), mobility (7%)
* Well placed to gain from the overall energy market transformation from electrification to automation and digitisation
Q4FY22 Results: Siemens reported a decent set of Q4FY22* numbers.
* Consolidated revenue was at | 4657.1 crore, up 8.4% YoY
* EBITDA came in at | 516 crore with margins of 11.1%, supported by stable gross margins
* Consequently, PAT came in at | 652.3 crore, up 102.8%
* Order inflow for Q4FY22 was decent at ~| 4009 crore, up 25% YoY
What should investors do? Overall, further penetration of automation & digitisation products and services across segments to drive long term growth.
* We remain long term positive and retain our BUY rating on the stock
Target Price and Valuation: We value Siemens at | 3630 on an SoTP basis.
Key triggers for future price performance:
* Strong focus on technology leadership in digitisation and automation products to further strengthen its market share
* Strong demand for short cycle products with clear traction from steel, cement, chemical, pharma, fertiliser industries to drive strong growth and margin expansion in smart infrastructure and digital industries segments
* Expect revenue, EBITDA to grow at a CAGR of ~18%, 18.6%, respectively, in FY22-24E owing to strong traction in short cycle products and services
Alternate Stock Idea: We also like ABB in our coverage.
* ABB continues to see a recovery in certain segments and industries like data centre, renewables, electronics, food & beverages and pharma. It continues to focus on order win and seamless execution across projects
* BUY with a target price of | 3635
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
SEBI Registration number INZ000183631
Above views are of the author and not of the website kindly read disclaimer
